Broadly protective human antibodies that target the active site of influenza virus neuraminidase
- 25 October 2019
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 366 (6464), 499-504
- https://doi.org/10.1126/science.aay0678
Abstract
Better vaccines against influenza virus are urgently needed to provide broader protection against diverse strains, subtypes, and types. Such efforts are assisted by the identification of novel broadly neutralizing epitopes targeted by protective antibodies. Influenza vaccine development has largely focused on the hemagglutinin, but the other major surface antigen, the neuraminidase, has reemerged as a potential target for universal vaccines. We describe three human monoclonal antibodies isolated from an H3N2-infected donor that bind with exceptional breadth to multiple different influenza A and B virus neuraminidases. These antibodies neutralize the virus, mediate effector functions, are broadly protective in vivo, and inhibit neuraminidase activity by directly binding to the active site. Structural and functional characterization of these antibodies will inform the development of neuraminidase-based universal vaccines against influenza virus.Keywords
Funding Information
- U.S. Department of Energy (DE-AC02-06CH11357)
- U.S. Department of Energy (DE-AC02-76SF00515)
- National Cancer Institute (Y1-CO-1020)
- National Institute of General Medical Sciences (Y1-GM-1104)
- National Institute of Allergy and Infectious Diseases (HHSN272201400008C)
- National Institute of Allergy and Infectious Diseases (AI117287)
- National Institute of Allergy and Infectious Diseases (AI117675)
- National Center for Advancing Translational Sciences (UL1TR002345)
- National Institute of Allergy and Infectious Diseases (AI139813)
- National Institute of Allergy and Infectious Diseases (AI141990)
This publication has 46 references indexed in Scilit:
- Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza virusesProceedings of the National Academy of Sciences of the United States of America, 2011
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A VirusesScience, 2011
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionThe Journal of Experimental Medicine, 2011
- Features and development of CootActa crystallographica. Section D, Structural biology, 2010
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa crystallographica. Section D, Structural biology, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa crystallographica. Section D, Structural biology, 2009
- Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigenNature Protocols, 2009
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa crystallographica. Section D, Structural biology, 1997
- [20] Processing of X-ray diffraction data collected in oscillation modeMethods in Enzymology, 1997